Stock Analysis

Pinning Down Allos S.A.'s (BVMF:ALOS3) P/S Is Difficult Right Now

BOVESPA:ALOS3
Source: Shutterstock

With a price-to-sales (or "P/S") ratio of 4.4x Allos S.A. (BVMF:ALOS3) may be sending bearish signals at the moment, given that almost half of all Real Estate companies in Brazil have P/S ratios under 3.2x and even P/S lower than 1.2x are not unusual. Although, it's not wise to just take the P/S at face value as there may be an explanation why it's as high as it is.

View our latest analysis for Allos

ps-multiple-vs-industry
BOVESPA:ALOS3 Price to Sales Ratio vs Industry August 8th 2024

What Does Allos' Recent Performance Look Like?

Allos certainly has been doing a good job lately as it's been growing revenue more than most other companies. It seems that many are expecting the strong revenue performance to persist, which has raised the P/S. If not, then existing shareholders might be a little nervous about the viability of the share price.

If you'd like to see what analysts are forecasting going forward, you should check out our free report on Allos.

How Is Allos' Revenue Growth Trending?

The only time you'd be truly comfortable seeing a P/S as high as Allos' is when the company's growth is on track to outshine the industry.

Taking a look back first, we see that the company grew revenue by an impressive 84% last year. The strong recent performance means it was also able to grow revenue by 258% in total over the last three years. Therefore, it's fair to say the revenue growth recently has been superb for the company.

Turning to the outlook, the next year should bring diminished returns, with revenue decreasing 4.4% as estimated by the eleven analysts watching the company. That's not great when the rest of the industry is expected to grow by 8.1%.

In light of this, it's alarming that Allos' P/S sits above the majority of other companies. Apparently many investors in the company reject the analyst cohort's pessimism and aren't willing to let go of their stock at any price. Only the boldest would assume these prices are sustainable as these declining revenues are likely to weigh heavily on the share price eventually.

The Final Word

Typically, we'd caution against reading too much into price-to-sales ratios when settling on investment decisions, though it can reveal plenty about what other market participants think about the company.

Our examination of Allos' analyst forecasts revealed that its shrinking revenue outlook isn't drawing down its high P/S anywhere near as much as we would have predicted. In cases like this where we see revenue decline on the horizon, we suspect the share price is at risk of following suit, bringing back the high P/S into the realms of suitability. This places shareholders' investments at significant risk and potential investors in danger of paying an excessive premium.

You should always think about risks. Case in point, we've spotted 2 warning signs for Allos you should be aware of.

If these risks are making you reconsider your opinion on Allos, explore our interactive list of high quality stocks to get an idea of what else is out there.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.